This Plain Language Summary of Publication from Future Rare Diseases describes the results from an ongoing study which looks at whether a new medicine called iptacopan can be used to treat a rare kidney disease called complement 3 glomerulopathy (C3G).

Read the full article here.

The original article on which this Plain Language Summary of Publication is based is titled ‘Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial’ and was published in Kidney International Reports. Read the original article here.